43219-27-8

Basic information

• Product Name: (2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-amine
• CAS NO: 43219-27-8
• Molecular Formula: C₂₀H₃₁N
• Molecular Weight: 285.4668
• Mol File: 43219-27-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 422.2°C at 760 mmHg
• Flash Point: 190.9°C
• Density: 0.932g/cm³
• Vapor Pressure: 2.46E-07mmHg at 25°C
• Refractive Index: 1.549
• CAS DataBase Reference: (2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-amine(CAS DataBase Reference)
• NIST Chemistry Reference: (2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-amine(43219-27-8)
• EPA Substance Registry System: (2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-amine(43219-27-8)

Safety Data

• Hazardous Substances Data: 43219-27-8(Hazardous Substances Data)

Upstream product

• 127-47-9 Retinol acetate 
• 23352-58-1 retinylimine 
• 43219-26-7 N-retinyl-phthalimide 

Downstream Products

• 43219-29-0 N-retinylacetamide 

Relevant articles and documents

Ligand binding induces conformational changes in human cellular retinol-binding protein 1 (CRBP1) revealed by atomic resolution crystal structures

Important in regulating the uptake, storage, and metabolism of retinoids, cellular retinol-binding protein 1 (CRBP1) is essential for trafficking Vitamin A through the cytoplasm. However, the molecular details of ligand uptake and targeted release by CRBP

METHODS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASE

A method is provided for treating a degenerative disease in a vertebrate eye. A method is further provided for preventing photoreceptor degeneration in a vertebrate eye.